[email protected]/(408) 457-3700

About RJSBio, Inc.

When fighting cancer, we cannot be focused on simply the destination of cancer drugs. A cancer drug’s journey to its intended target is a key component to its ultimate success or failure. At RJSBio we define the path of a cancer drug to, and within, a cancer cell using fully-synthetic drug conjugates. Modification of existing drugs is a proven strategy for quick access to the market.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
Seattle
Markets:
Pharmaceuticals
Therapeutic Areas:
Oncology